A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

As competitive as the obesity drug market has become, Novo Nordisk's decision to slash the prices of its GLP-1 agonist drugs ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

A WEIGHT loss pill set to be available next year will be a cheaper, easier and effective alternative to Mounjaro injections, ...

Novo Nordisk moved to cut U.S. prices on its leading GLP-1 weight-loss and diabetes drugs as competitive pressure from Eli ...

Ozempic (semaglutide) is a prescription medication that's approved by the US Food and Drug Administration (FDA) for both managing blood sugar in adults with type 2 diabetes and for reducing the risk ...

Wegovy and Ozempic prices have dropped as Novo Nordisk cuts costs for most versions of the popular weight-loss and diabetes ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new research suggests they may also reduce the risk of early death in colon cancer ...

Amycretin also improved participants’ blood sugar levels in positive sign for Danish company’s treatment pipeline ...